This inventor holds 1 USPTO granted patent. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, University of Cincinnati. Active years: 2006.
Company Filing History:
1 out of 3,690 
1 out of 556 
Years Active: 2006
Title: George S Deepe: Innovator in Nucleotide Sequence Technology
Introduction
George S Deepe is a notable inventor based in Terrace Park, OH (US). He has made significant contributions to the field of biotechnology, particularly in the area of nucleotide sequences. His work has implications for diagnosing infections and developing treatments.
Latest Patents
George S Deepe holds 1 patent. His patent provides the nucleotide sequence of the M antigen gene, which is detailed in the Sequence Listing as SEQ ID NO:1. The invention includes a nucleic acid with a complementary nucleotide sequence and other related sequences. Additionally, it encompasses vectors and host expression systems containing these nucleic acids, as well as isolated or recombinantly-produced antigens. The patent also covers antibodies generated against these antigens and methods for detecting infections, specifically for diagnosing histoplasmosis.
Career Highlights
Throughout his career, George S Deepe has worked with prominent organizations, including the United States Department of Health and Human Services and the University of Cincinnati. His contributions have advanced the understanding of genetic sequences and their applications in medicine.
Collaborations
George has collaborated with notable individuals in his field, including Rosely M Zancope-Oliveira and Leonard W Mayer. These partnerships have fostered innovation and research in nucleotide technology.
Conclusion
George S Deepe's work in nucleotide sequence technology has paved the way for advancements in medical diagnostics and treatment. His contributions continue to impact the field of biotechnology significantly.